{"id":"W2136451994","doi":"10.1310/7lyw-gqff-wprq-k3qw","title":"Clinical Impact of Double Protease Inhibitor Boosting with Lopinavir/Ritonavir and Amprenavir as Part of Salvage Antiretroviral Therapy","year":2003,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"ca_institutions":"St. Michael's Hospital; Women's College Hospital; Health Sciences Centre; Canadians Living with HIV; Sunnybrook Health Science Centre; University of Waterloo; University Health Network; University of Toronto; Montreal General Hospital; McGill University","funders":"Abbott Laboratories","keywords":"Lopinavir; Medicine; Amprenavir; Ritonavir; Regimen; Salvage therapy; Internal medicine; Hazard ratio; Atazanavir; Lopinavir/ritonavir; Protease inhibitor (pharmacology); Viral load; Human immunodeficiency virus (HIV); Antiretroviral therapy; Confidence interval; Immunology; Protease; Chemotherapy; HIV-1 protease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009544148,0.0002239485,0.0005133756,0.0001196075,0.0002992241,0.000638827,0.0002337872,0.0003473528,0.00148375],"category_scores_gemma":[0.002741289,0.0001271727,0.0006999219,0.000171279,0.0001712716,0.0002501124,0.0002441818,0.0007897411,0.0001841087],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006188729,"about_ca_system_score_gemma":0.0008501318,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001582986,"about_ca_topic_score_gemma":0.00193303,"domain_scores_codex":[0.9993088,0.0001954418,0.00005450678,0.0001402149,0.0001794614,0.0001215594],"domain_scores_gemma":[0.9982595,0.0004357062,0.0006062703,0.00008937762,0.00009398934,0.0005151422],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.02726315,0.003647885,0.9008267,0.0001167675,0.0005094021,0.0008192155,0.0001454072,0.0003879189,0.004627092,0.00009048801,0.0005942521,0.06097179],"study_design_scores_gemma":[0.001409168,0.02995154,0.9606789,0.00005943044,0.0005528899,0.001903291,0.0001919168,0.001834803,0.001800812,0.00007061269,0.001530075,0.00001650813],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.998964,0.0004889294,0.00004637587,0.00004671238,0.00001270898,0.00001730149,0.00005709969,0.000002932309,0.0003639647],"genre_scores_gemma":[0.999396,0.0001479081,0.00008388975,0.000066187,0.00002093681,0.000008577917,0.0001478653,0.000001152215,0.0001274427],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001582986,"threshold_uncertainty_score":0.0050475,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2044627533897381,"score_gpt":0.483843551421669,"score_spread":0.2793807980319309,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}